Company triumphs at prestigious Asia awards ceremony celebrating outstanding bioprocessing performance within Korea and worldwide
Peli BioThermal, a global temperature-controlled packaging provider, was announced as the winner of the Bioprocessing Excellence in Passive Packaging Solutions in Korea at a leading Asia awards ceremony celebrating excellence within the biopharma industry.
Peli BioThermal won the prestigious award after being acknowledged as biopharma “industry leaders and trend-setters” at the 9th Annual Biologics Manufacturing Korea 2020 – Korea Bioprocessing Excellence Awards (KBEA).
“We are very proud to be announced again as award winners in Asia and it is a significant achievement to be the recipients of another major award, which recognizes our outstanding excellence within the sector,” said Benson Teo, Peli BioThermal’s Senior Director of Sales, Asia.
“We are thrilled this latest accolade highlights the exceptionally high performance of our passive packaging solutions and further demonstrates how Peli BioThermal continues to lead the way within the industry in Asia and globally, with its innovative award-winning thermal protection shipper solutions and exceptional services.”
The award win was announced as Peli BioThermal continues to expand its growing network of facilities within Asia, having recently unveiled its latest new drop point and network station situated in Incheon, South Korea. The new facility is part of the company’s ongoing expansion of more than 100 major sites located globally to best serve the life sciences sector.
The virtual awards ceremony was held on October 22, 2020, in conjunction with the 9th Annual Biologics Manufacturing Korea 2020 conference, which saw more than 600 representatives from Korea’s leading biologic manufacturers, companies and organizations gather for the KBEA awards event.
More information on the wide range of Peli BioThermal products and offerings is available at www.pelibiothermal.com.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.